Access to medicines and health products

Access to medicines and health products

Universal health coverage can only be achieved when there is affordable access to safe, effective and quality medicines and health products. Countries face a range of obstacles to achieving this, including rising prices for new medicines; shortages and stock outs of essential medicines, especially for noncommunicable diseases, and the growing problem of substandard and falsified medical products entering the global supply chain. Added to this, there are other challenges to ensuring that medicines are not only available, but are used appropriately.

Antimicrobial resistance has become a worldwide problem largely due to overuse, and misuse of opioids has led to an addiction epidemic in some countries. Knowing where to tackle the problem is the first step. WHO works with Member States to identify what their priorities are on the road to achieving this universal access.

Departments

Contact us

Regions contact

AFRO AMRO │ EMRO │ EURO 

SEARO │ WPRO

Adopt AWaRe: Handle antibiotics with care

AWaRe Portal

We can reduce or even reverse antibiotic resistance by using antibiotics more responsibly. But how do we do that and still ensure that patients are treated effectively? WHO has developed a tool to help global, regional and national decision-making on which antibiotics to use when.

 

Our work

All →

Technical information

Publications

All →
WHA 71.8 - Progress Indicators for access to assistive technology
The 71st World Health Assembly (WHA) adopted resolution WHA71.8 on 26 May 2018. It urges all Member States to take action to improve access to assistive...
WHO Expert Committee on Biological Standardization: seventy-fourth report

The seventy-fourth meeting of the WHO Expert Committee on Biological Standardization was held from 18 to 22 October 2021 via video conference due to the...

WHO Drug Information - Volume 36, No. 1

The first issue of Volume 36, includesConsultation Documents:Tenofovir disoproxil fumarate (tenofoviri disoproxili fumaras)Molnupiravir capsules (molnupiraviri...

WTO agreements and public health : a joint study by the WHO and WTO secretariat

This comprehensive document deals with the relevant WTO agreements and the way they may influence health and health policies. In undertaking this joint...

World Local Production Forum: Enhancing access to medicines and other health technologies

The World Local Production Forum: Enhancing access to medicines and other health technologies (WLPF) brings the global community – foremost government...

Related health topics

All →